AU655598B2 - Vitaletheine and use in cell culture and therapy - Google Patents

Vitaletheine and use in cell culture and therapy Download PDF

Info

Publication number
AU655598B2
AU655598B2 AU85008/91A AU8500891A AU655598B2 AU 655598 B2 AU655598 B2 AU 655598B2 AU 85008/91 A AU85008/91 A AU 85008/91A AU 8500891 A AU8500891 A AU 8500891A AU 655598 B2 AU655598 B2 AU 655598B2
Authority
AU
Australia
Prior art keywords
cell
vitaletheine
cells
modulator
modulators
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU85008/91A
Other languages
English (en)
Other versions
AU8500891A (en
Inventor
Galen Daryl Knight
Terence Joseph Scallen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of New Mexico UNM
Original Assignee
University of New Mexico UNM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of New Mexico UNM filed Critical University of New Mexico UNM
Publication of AU8500891A publication Critical patent/AU8500891A/en
Application granted granted Critical
Publication of AU655598B2 publication Critical patent/AU655598B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/0025—Culture media for plant cell or plant tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40—Y being a hydrogen or a carbon atom
    • C07C323/41—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU85008/91A 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy Ceased AU655598B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US549438 1983-11-07
US54910590A 1990-07-06 1990-07-06
US54943890A 1990-07-06 1990-07-06
US54944090A 1990-07-06 1990-07-06
US549105 1990-07-06
US549440 1990-07-06
PCT/US1991/004726 WO1992000955A1 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Publications (2)

Publication Number Publication Date
AU8500891A AU8500891A (en) 1992-02-04
AU655598B2 true AU655598B2 (en) 1995-01-05

Family

ID=27415550

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85008/91A Ceased AU655598B2 (en) 1990-07-06 1991-07-08 Vitaletheine and use in cell culture and therapy

Country Status (9)

Country Link
EP (1) EP0539525B1 (enExample)
JP (1) JP3259960B2 (enExample)
AT (1) ATE186048T1 (enExample)
AU (1) AU655598B2 (enExample)
DE (1) DE69131752T2 (enExample)
DK (1) DK0539525T3 (enExample)
ES (1) ES2139580T3 (enExample)
GR (1) GR3031801T3 (enExample)
WO (1) WO1992000955A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718140B2 (en) * 1995-10-17 2000-04-06 Dovetail Technologies, Inc. Low molecular weight cell, bone marrow and immune stimulants

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552765A (en) * 1982-05-14 1985-11-12 Santen Pharmaceutical Co., Ltd. Aletheine derivatives
JP3319597B2 (ja) * 1990-07-06 2002-09-03 ユニバシテイ オブ ニュー メキシコ 細胞培養及び治療に有用なβ―アレチン

Also Published As

Publication number Publication date
GR3031801T3 (en) 2000-02-29
DK0539525T3 (da) 2000-04-10
JPH06500106A (ja) 1994-01-06
JP3259960B2 (ja) 2002-02-25
HK1014367A1 (en) 1999-09-24
DE69131752D1 (de) 1999-12-02
DE69131752T2 (de) 2000-06-29
EP0539525B1 (en) 1999-10-27
ES2139580T3 (es) 2000-02-16
ATE186048T1 (de) 1999-11-15
EP0539525A4 (enExample) 1994-01-12
AU8500891A (en) 1992-02-04
EP0539525A1 (en) 1993-05-05
WO1992000955A1 (en) 1992-01-23

Similar Documents

Publication Publication Date Title
PRASAD Morphological differentiation induced by prostaglandin in mouse neuroblastoma cells in culture
Fukuda K562 human leukaemic cells express fetal type (i) antigen on different glycoproteins from circulating erythrocytes
EP0571390B1 (en) The delay, prevention and/or reversal of cell senescence
US6323025B1 (en) In vitro cell culture in media containing beta-alanyl-taurine or carbobenzoxy beta-alanyl-taurine
US5578313A (en) Therapeutic use of vitaletheine modulators in neoplasia
JPS63211225A (ja) 抗腫瘍性スペルミン誘導体
Litwin The effect of light on the aging of human diploid fibroblasts
AU655598B2 (en) Vitaletheine and use in cell culture and therapy
Moser Modern approaches to the study of mammalian cells in culture
EP0220379A1 (de) Verwendung von Glutamin in Form seiner Di- und Tripeptide im Nährmedium für Zellkulturen
AU646875B2 (en) Beta-alethine use in cell culture and therapy
US20030166715A1 (en) Use of vitaletheine modulators in the prophylaxis and treatment of disease
HK1014367B (en) Vitaletheine and use in cell culture and therapy
US6245561B1 (en) β-alethine use in cell culture and therapy
CA2481110A1 (en) Vitaletheine and use in cell culture and therapy
Krohn Litters from C 3 H and CBA Ovaries orthotopically transplanted into Tolerant A Strain Mice
US2599587A (en) Process of preparing an antibacterial substance from pyridoxamine
Cheng High molecular weight ribonucleic acids from the nuclei of calf thymus
Willson et al. Biological properties of amidinium sulfinic and sulfonic acid derivatives: inhibition of glycolytic enzymes of Trypanosoma brucei and protective effect on cell growth
CA2087884C (en) Vitaletheine and use in cell culture and therapy
CA2087883C (en) Beta-alethine use in cell culture and therapy
EP0123446B1 (en) 2-furylbutyrolactone derivatives, their preparation, compositions containing them, and their use for the modulation of the immune system in mammals
Shivaji et al. Mode of action of alkylating agents using a ciliate protozoan as a model system II. effect of metepa on RNA and protein synthesis in Stylonychia notophora (ciliata: hypotrichida)
Janeček et al. Influence of DL-beta-phenylserine on the synthesis of proteins in Escherichia coli
EP0299413B1 (en) New tetramethyl-cis-diaza-bicyclo[4.2.0]octane-3,5-dione derivatives having a differentiation-inducing activity